Ailing reactors and their isotopes: radiopharmacy and nuclear research in Belgium (1990–2020)

Read full text Summarise with VIRAT
Authors: Hein Brookhuis
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This article studies the relation between research reactors, the development of nuclear research centres and the pharmaceutical industry in the recent history of nuclear medicine. While existing scholarship has rightfully highlighted how medical applications served as a useful argument to de-militarize the image of large-scale nuclear research infrastructure during the Cold War, this study extents this perspective beyond the Cold War era. Using the Belgian Nuclear Research Centre as a case study, this article highlights how their orientation was negotiated within economic and political considerations. From the 1990s onwards, therapeutic radiopharmaceuticals experienced increasing attention, while the amount of radioisotope-producing reactors was decreasing. In an era that had become more critical of nuclear infrastructure, this article shows how the production of radioisotopes became a social-political argument in the preservation of test reactors.

Fields of Study & Subjects

Twentieth Century Scientific Developments History of Science and Medicine Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
Medical History
Volume
70
Issue
4
Pages
515–529
Publication date
26 March 2026
Language
EN